Staphylococcus aureus toxin antibodies: Good companions of antibiotics and vaccines

Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus

(2017) Melissa J. Karau et al.   Virulence

Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax

(2016) Wilbur H. Chen et al.   Clinical and Vaccine Immunology

Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies

(2016) Adriana Badarau et al.   mAbs

MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model

(2015) L. Hua et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Novel antibody–antibiotic conjugate eliminates intracellular S. aureus

(2015) Sophie M. Lehar et al.   NATURE

Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond

(2015) Natasha Holmes et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Efficacy profile of a bivalent Staphylococcus aureusglycoconjugated vaccine in adults on hemodialysis: Phase III randomized study

(2015) Ali Fattom et al.   Human Vaccines & Immunotherapeutics

Five birds, one stone: Neutralization of α-hemolysin and 4 bi-component leukocidins ofStaphylococcus aureuswith a single human monoclonal antibody

(2014) Harald Rouha et al.   mAbs

Selection of high-affinity Centyrin FN3 domains from a simple library diversified at a combination of strand and loop positions

(2014) Michael D. Diem et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus

(2014) Michael R. Yeaman et al.   Frontiers in Immunology

Staphylococcus aureus Infections After Elective Cardiothoracic Surgery: Observations From an International Randomized Placebo-Controlled Trial of an Investigational S aureus Vaccine

(2014) Keith B. Allen et al.   Open Forum Infectious Diseases

Assessment of an Anti-Alpha-Toxin Monoclonal Antibody for Prevention and Treatment of Staphylococcus aureus-Induced Pneumonia

(2013) L. Hua et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The staphylococcal enterotoxin (SE) family

(2013) Teresa Krakauer et al.   Virulence

Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

(2012) R. G. Wunderink et al.   CLINICAL INFECTIOUS DISEASES

Inferring Reasons for the Failure of Staphylococcus aureus Vaccines in Clinical Trials

(2012) Fabio Bagnoli et al.   Frontiers in Cellular and Infection Microbiology

Advances in the production and downstream processing of antibodies

(2011) John H. Chon et al.   New Biotechnology

Chimeric Anti-Staphylococcal Enterotoxin B Antibodies and Lovastatin Act Synergistically to Provide In Vivo Protection against Lethal Doses of SEB

(2011) Mulualem E. Tilahun et al.   PLoS One

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

(2010) E. Rubinstein et al.   CLINICAL INFECTIOUS DISEASES

Potent Neutralization of Staphylococcal Enterotoxin B by Synergistic Action of Chimeric Antibodies

(2010) M. E. Tilahun et al.   INFECTION AND IMMUNITY

Recent advances in large-scale production of monoclonal antibodies and related proteins

(2010) Abhinav A. Shukla et al.   TRENDS IN BIOTECHNOLOGY

Cytolysins Augment Superantigen Penetration of Stratified Mucosa

(2009) A. J. Brosnahan et al.   JOURNAL OF IMMUNOLOGY

Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE

(2008) Louis B. Rice   JOURNAL OF INFECTIOUS DISEASES